biovisionK894-100CYP1A2 inhibitor screening kit, CYP1A2 inhibitor kit, CYP inhibitor screening, screen cytochrome P450 inhibitors, study Cytochrome P450 1A2 inhibitors, characterize CYP inhibitors, characterize CYP ligands, CYP1A2 inhibitor, CYP1A inhibitor screening kit, cyp1a inhibitor kit, cytochrome inhibitor screening, screen cyp1a2 inhibitors, screen cyp1a ligands, screen CYP1A2 inhibitors, CYP1A2 ligands, study cytochrome P450 1A2 inhibitors, characterize cyp1A2 inhibitors, Cyt P450 inhibitor, Cyt P450 1A2 drug screening, Cytochrome P450 ligand screening kit, CypIA2 ligand screening kit, CYP1A2 inhibitor screening, screen inhibitors of CYP enzymes, study cytochrome P450 inhibitors, characterize CYP inhibitors, Cytochrome P450 ligands, cytochrome P450 1A2, September-AK-15 ? Detection method - Fluorescence (Ex/Em 406/468 nm) ? Species reactivity - Eukaryotes ? Applications - ? Rapid, high-throughput screening of drugs and novel ligands. ? Development of structure-activity relationship (SAR) models to predict CYP1A2 inhibition liability of novel compounds. ? Prediction of adverse drug-drug interaction potential and bioavailability for compounds metabolized by CYP1A2.? Rapid, high-throughput screening of drugs and novel ligands. ? Development of structure-activity relationship (SAR) models to predict CYP1A2 inhibition liability of novel compounds. ? Prediction of adverse drug-drug interaction potential and bioavailability for compounds metabolized by CYP1A2.Samples containing drugs, inhibitors or ligands (compounds that can interact and affect CYP1A2 activity)